| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S2104-Panc,Resect High-risk,Postop Adj Chemo vs Obs | 1 | Y | 1 Capecitabine Temozolomide | 154 | 69 | 18 | 12 | 3 | 1 | 0 | 05/05/2022 | 222 | 74 |
| 2 Observation | 37 | 9 | 4 | 3 | 1 | 0 | ||||||||
| 106 | 27 | 16 | 6 | 2 | 0 | |||||||||
| S2303-Gas/Esoph/GEJ, Adv, Ram + Pac +/- Nivo | 1 | Y | 1 Nivolumab + Paclitaxel + Ramucirumab | 224 | 57 | 34 | 14 | 7 | 1 | 0 | 06/24/2024 | 260 | 90 | |
| 2 Paclitaxel + Ramucirumab | 58 | 32 | 15 | 9 | 5 | 2 | ||||||||
| 115 | 66 | 29 | 16 | 6 | 2 | |||||||||
| S2433-PANC, KRAS WT, Met, SOC Chemo +/- Panitumumab | 1 | Y | 1 Panitumumab + Chemotherapy | 94 | 1 | 1 | 1 | 0 | 0 | 0 | 05/13/2026 | 158 | 48 | |
| 1 | 1 | 1 | 0 | 0 | 0 | |||||||||
| Yes | A022102-Gastric, FOLFIRINOX +/-Nivo vs FOLFOX +/ Nivo | 1 | E | Total Registrations | 42 | 10 | 5 | 3 | 1 | 0 | 05/15/2023 | 256 | 101 | |
| 42 | 10 | 5 | 3 | 1 | 0 | |||||||||
| EA2174-Esoph, Peri-Op Nivolumab +/- Ipilimumab | 1 | E | Total Registrations | 6 | 0 | 0 | 0 | 0 | 0 | 06/01/2021 | 270 | 82 | ||
| 6 | 0 | 0 | 0 | 0 | 0 | |||||||||
| 2 | E | Total Registrations | 3 | 0 | 0 | 0 | 0 | 0 | 06/01/2021 | |||||
| 3 | 0 | 0 | 0 | 0 | 0 | |||||||||
| EA2192-Panc, APOLLO | 0 | E | Total Registrations | 9 | 1 | 0 | 0 | 0 | 0 | 12/07/2022 | 160 | 76 | ||
| 9 | 1 | 0 | 0 | 0 | 0 | |||||||||
| 1 | E | Total Registrations | 7 | 1 | 1 | 1 | 1 | 1 | 12/07/2022 | |||||
| 7 | 1 | 1 | 1 | 1 | 1 | |||||||||
| NRGGI008-Colon, Stg III, Adj Chemo | 1 | E | Total Registrations | 95 | 40 | 21 | 11 | 5 | 1 | 12/08/2022 | 538 | 201 | ||
| 95 | 40 | 21 | 11 | 5 | 1 | |||||||||
| 2 | E | Total Registrations | 76 | 37 | 19 | 9 | 1 | 1 | 12/08/2022 | |||||
| 76 | 37 | 19 | 9 | 1 | 1 | |||||||||
| 3 | E | Total Registrations | 1 | 1 | 0 | 0 | 0 | 0 | 12/08/2022 | |||||
| 1 | 1 | 0 | 0 | 0 | 0 | |||||||||
| No | A022101-Colorectal, Metastatic, Ablative Tx | 0 | E | Total Registrations | 2 | 0 | 0 | 0 | 0 | 0 | 07/12/2024 | 175 | 68 | |
| 2 | 0 | 0 | 0 | 0 | 0 | |||||||||
| 1 | E | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 07/12/2024 | |||||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| A212101-Colorectal, New Dx. Gen Testing | 1 | E | Total Registrations | 7 | 7 | 7 | 7 | 0 | 0 | 06/17/2026 | 11 | 7 | ||
| 7 | 7 | 7 | 7 | 0 | 0 | |||||||||
| 2 | E | Total Registrations | 1 | 1 | 1 | 1 | 1 | 0 | 06/17/2026 | |||||
| 1 | 1 | 1 | 1 | 1 | 0 | |||||||||
| CCTGCO32-Rectal, Early Stg, Neoadj/Exc/Obs vs ChemRad | 1 | E | Total Registrations | 16 | 8 | 5 | 2 | 1 | 0 | 06/26/2024 | 179 | 58 | ||
| 16 | 8 | 5 | 2 | 1 | 0 | |||||||||
| CCTGNE1-Midgut NET, Unresect, 177 Lut vs Ever | 1 | E | Total Registrations | 9 | 5 | 2 | 2 | 1 | 0 | 06/11/2024 | 66 | 21 | ||
| 9 | 5 | 2 | 2 | 1 | 0 | |||||||||
| EA2222-Colorectal, Stg II-III, Hep Art Infusion | 1 | E | Total Registrations | 9 | 5 | 2 | 1 | 0 | 0 | 06/12/2024 | 127 | 45 | ||
| 9 | 5 | 2 | 1 | 0 | 0 | |||||||||
| EA2234-Gastric, all stg, Pac+Sys vs Sys | 0 | E | Total Registrations | 1 | 1 | 0 | 0 | 0 | 0 | 03/04/2026 | 182 | 58 | ||
| 1 | 1 | 0 | 0 | 0 | 0 | |||||||||
| 1 | E | Total Registrations | 1 | 1 | 1 | 0 | 0 | 0 | 03/04/2026 | |||||
| 1 | 1 | 1 | 0 | 0 | 0 | |||||||||
| NRGGI004-Colorectal, Stg IV, dMMR Immuno-Therapy | 1 | Y | Total Registrations | 15 | 0 | 0 | 0 | 0 | 0 | 04/18/2018 | 289 | 89 | ||
| 15 | 0 | 0 | 0 | 0 | 0 | |||||||||
| NRGGI005-COLON,Stg IIA, ctDNA in Adjuvant Chemotherapy | 1 | Y | Total Registrations | 35 | 0 | 0 | 0 | 0 | 0 | 07/06/2020 | 440 | 147 | ||
| 35 | 0 | 0 | 0 | 0 | 0 | |||||||||